Energy metabolism in Japanese patients with Crohn's disease

Journal of Clinical Biochemistry and Nutrition

Volumn 46, Issue 1, 2010, Pages 68-72

  Sasaki, Masaya ^a   Johtatsu, Tomoko ^a   Kurihara, Mika ^a   Iwakawa, Hiromi ^a   Tanaka, Toshihiro ^a   Tsujikawa, Tomoyuki ^a   Fujiyama, Yoshihide ^a   Andoh, Akira ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Crohn's disease; Indirect calorimetry; Resting energy expenditure

Indexed keywords

INFLIXIMAB; PREDNISONE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIET THERAPY; ELEMENTAL DIET; ENERGY EXPENDITURE; ENERGY METABOLISM; FEMALE; HOSPITAL PATIENT; HUMAN; JAPANESE; MALE; MALNUTRITION; OVERNUTRITION; TOTAL PARENTERAL NUTRITION; WEIGHT REDUCTION;

EID: 77249111886     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.09-55     Document Type: Article

References (28)

1. Farmer, R.G., Hawk, W.A., and Turnbull, R.B. Jr.: Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology, 68, 627-635, 1975.
2. Mekhjian, H.S., Switz, D.M., Melnyk, C.S., Rankin, G.B., and Brooks, R.K.: Clinical features and natural history of Crohn's disease. Gastroenterology, 77, 898-906, 1979.
3. Afonso, J.J. and Rombeau, J.L.: Nutritional care for patients with Crohn's disease. Hepatogastroenterology, 37, 32-41, 1990.
4. Driscoll, R.H. and Resenberg, J.L.: Total parenteral nutrition in inflammatory bowel disease. Med. Clin. North Am., 62, 185-201, 1978.
5. Fillipi, J., Al-Jaouni, R., Wiroth, J.B., Hebuterne, X., and Schneider, S.M.: Nutritional deficiencies in patients with Crohn's disease in remission, lnflamm. Bowel. Dis., 12, 185-191, 2006.
6. Hodges, P., Gee, M., Grace, M., Sherbaniuk, R.W., Wensel, R.H., and Thomson, A.B.: Protein-energy intake and malnutrition in Crohn's disease. J. Am. Diet Assoc., 84, 1460-1464, 1984.
7. Geerling, B.J., Badart-Smook, A., Stockbrugger, R.W., and Brummer, R.J.: Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am. J. Clin. Nutr., 67, 919-926, 1998.
8. Johtatsu, T., Andoh, A., Kurihara, M., Iwakawa, H., Tsujikawa, T., Kashiwagi, A., Fujiyama, Y., and Sasaki, M.: Serum concentration of trace elements in patients with Crohn's disease receiving enteral nutrition. J. Clin. Biochem. Nutr., 41, 197-201, 2007.
9. O'Morain, C, Segal, A.W., and Levi, A.J.: Elemental diet therapy as primary therapy of acute Crohn's disease. Br. Med. J., 288, 1859-1862, 1984.
10. Hunter, J.O.: Nutrition factors in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol., 10, 235-237, 1988.
11. Takagi, S., Utsunomiya, K., Kuriyama, S., Yokoyama, H., Takahashi, S., Iwabuchi, M., Takahashi, H., Takahashi, S., Kinouchi, Y., Hiwatashi, N., Funayama, Y., Sasaki, I., Tsuji, I., and Shimosegawa, T.: Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: A randomized-controlled trial. Aliment. Pharmacol. Ther., 24, 1333-1340,2006.
12. Chan, A.T., Fleming, C.R., O'Fallon, W.M., and Huizenga, K.A.: Estimated versus measured basal energy requirement in patients with Crohn's disease. Gastroenterology, 91, 75-78, 1986.
13. Kushner, R.F. and Schoeller, D.A.: Resting and total energy expenditure in patients with inflammatory bowel disease. Am. J. Clin. Nutr., 53, 161-165, 1991.
14. Stokes, M.A. and Hill, G.L.: Total energy expenditure in patients with Crohn's disease: measured by the combined body scan technique. JPEN, 17, 3-7, 1993.
15. Rigaud, D., Cerf, M., Angel, Alberto. L., Sobhani, I., and Mignon, M.: Increase of resting energy expenditure during flare-ups in Crohn's disease. Gastroenterol Clin. Biol., 17, 932-937, 1993.
16. AI-Janouni, R., Hebuterne, X., Pouget, I., and Rampai, P.: Energy metabolism and substrate oxidation in patients with Crohn's disease. Nutrition, 16, 173-178, 2000.
17. Melchior, J.C., Salmon, D., Rigaud, D., Leport, C., Bouvet, E., Detruchis, P., Vilde, J.L., Vachon, F., Coulaud, J.R., and Apfelbaum, M.: Resting energy expenditure is increased in stable, malnourished HIV-infected patients. Am. J. Clin. Nutr., 53, 437-441, 1991.
18. Schneeweiss, B., Lochs, H., Zauner, C., Fischer, M., Wyatt, J., Maier-Dobersberger, T., and Schneider, B.: Energy and substrate metabolism in patients with active Crohn's disease. J. Nutr., 129, 844-848, 1999.
19. Harris, J.A. and Benedict, F.G.: A biometric study of human basal metabolism. Proc. Natl. Acad. Sci U.S.A., 4, 370-373, 1918.
20. Long, C.L., Schaffel, N., Geiger, J.W., Schiller, W.R., and Blakemore, W.S.: Metabolic response to injury and illness: Estimation of energy and protein needs from indirect calorimetry and nitrogen balance. J. Parenteral. Entr. Nutr., 3, 452-456, 1979.
21. Weir, J.B.V: New methods for calculating metabolic rate with special reference to protein matabolism. J. Physiol., 109, 254-259, 1949.
22. Han, P.D., Burke, A., Baldassano, R.N., Rombeau, J.L., and Lichtenstein, G.R.: Nutritional and inflammatory bowel disease. Gatroenterol. Clin. North Am., 28, 423-443, 1999.
23. Barot, L.R., Rombeau, J.L., Feurer, I.D., and Mullen, J.L.: Caloric requirement in patients with inflammatory bowel disease. Ann. Surg., 195, 214-218, 1982.
24. Ida, M.: Pharmacological therapy in Crohn's disease. Annual Report of the Research Committee of Inflammatory Bowel Disease, The Japanese Ministry of Health, Labor and Welfare, pp. 21-22, 2003 (In Japanese).
25. Lochs, H., Dejong, C., and Hammarqvist, F.: ESPEN guidelines on enteral nutrition: gastroenterology. Clin. Nutr., 25, 260-274, 2006.
26. Vaisman, N., Dotan, I., Halack, A., and Niv, E.: Malabsorption is a major contributor to underweight in Crohn's disease patients in remission. Nutrition, 22, 855-859, 2006.
27. Mingrone, G., Benedetti, G., Capristo, E., De Gaetano, A., Greco, A.V., Tataranmi, P.A., and Gasbarrini, G.: Twenty-four-hour energy balance in Crohn's disease patients: metabolic implication of steroid treatment. Am. J. Clin. Nutr., 67, 118-123, 1998.
28. Wiese, D., Lashner, B., and Seidner, D.: Measurement of nutrition status in Crohn's disease patients receiving Infliximab therapy. Nutr. Clin. Pract., 23, 551-556, 2008.